XML 56 R4.htm IDEA: XBRL DOCUMENT

Award Timing Disclosure

12 Months Ended

Dec. 31, 2024

Mar. 01, 2024

USD ($)

$ / shares

Award Timing Disclosures [Line Items]

Award Timing MNPI Disclosure

Timing of LTI Grants

Our practice has been to grant LTI equity awards on a predetermined schedule. As part of our annual performance and compensation review process, the Committee reviews and approves annual equity awards (inclusive of Stock Options, Restricted Stock Units and Performance Share Units) at the first quarterly meeting of each fiscal year, which occurs after the announcement

of our annual results. Beginning in 2024, the grant date for annual equity awards has been established as March 1 of each year, which typically follows the filing of our Annual Report on Form

10-K

by a week or more. The intention of this timing was to choose a consistent date that would be at least a week removed from the announcement of annual results and filing of the

Form 10-K.

In addition to the annual grants, equity awards may be granted at other times during the year to new hires, employees receiving promotions, and in other special circumstances. The Committee does not take material nonpublic information into account when determining the timing and terms of equity awards, and we do not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.

For stock option awards, the exercise price is the closing sale price of our common stock on the NYSE on the date of the grant. If the grant date falls on a

non-trading

day, the exercise price is the closing price of our common stock on the NYSE on the last trading day preceding the date of grant.

As required by Item 402(x) of Regulation

S-K

under the Securities Exchange Act of 1934, we are providing the following information about the stock options granted to our NEOs on March 1, 2024, which is within four business days before our filing of a Form

8-K

on March 5, 2024, disclosing information to be presented by our executives to investors at the Raymond James Institutional Investors Conference:


Name	Grant Date		Number of Securities Underlying the Award		Exercise Price of the Award ($/Sh)		Grant Date Fair Value of the Award ($)		Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information

Engel		3/1/2024		29,146		$152.07		$2,099,969		2.7	%

Schulz		3/1/2024		7,564		$152.07		$ 544,986		2.7	%

Geary		3/1/2024		5,205		$152.07		$ 375,020		2.7	%

Squires		3/1/2024		5,205		$152.07		$ 375,020		2.7	%

Khurana		3/1/2024		4,164		$152.07		$ 300,016		2.7	%

Award Timing Method

Beginning in 2024, the grant date for annual equity awards has been established as March 1 of each year, which typically follows the filing of our Annual Report on Form

10-K

by a week or more. The intention of this timing was to choose a consistent date that would be at least a week removed from the announcement of annual results and filing of the

Form 10-K.

In addition to the annual grants, equity awards may be granted at other times during the year to new hires, employees receiving promotions, and in other special circumstances

Award Timing Predetermined

true

Award Timing MNPI Considered

false

MNPI Disclosure Timed for Compensation Value

false

Engel [Member]

Awards Close in Time to MNPI Disclosures

Name

Engel

Underlying Securities | shares

29,146